Gain Therapeutics Inc. (GANX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 158,155 $3,737,203 -53% 0.03%
2.
Greenlight Capital

David Einhorn

566,130 $1,222,841 0.06%
3.
Marshall Wace LLP

Paul Marshall And Ian Wace

91,738 $198,155 0%
4.
Springbok Capital

Gavin Saitowitz And Cisco J. Del Valle

35,820 $77,371 0%
5. 14,000 $30,240 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.01 14,400 Officer 14,400 2024-08-09 Filing
$1.00 50,000 Officer, Director 50,000 2024-08-09 Filing
$1.21 12,000 Director 289,629 2024-07-01 Filing
$1.23 5,000 Director 277,629 2024-07-01 Filing
$3.86 30,000 Director 30,000 2024-03-28 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.46 206 Officer, Director 5,286 2023-12-21 Filing
$2.50 1,820 Officer, Director 4,855 2023-12-07 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 267,421 $577,701 0%
2. 177,075 $382,482 0%
3. 98,250 $212,220 0%
4. 88,512 $191,186 0%
5. 86,061 $185,892 0%
News See All